From: Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial
CTRX (n = 124)
ABPC/SBT (n = 139)
p-value
Diarrhea
12
7
0.23
Rash
5
0.55
Elevated AST or ALT
4
1.00
Leukopenia
1
Nausea
Fever
0
0.48
Elevated creatine kinase
Total
25 (22 patients)
20 (19 patients)